Researchers have found that the knockdown of COL1A1 can inhibit the EMT process through the TGF-β signaling pathway, thereby inhibiting the invasion and metastasis of liver cancer and bladder cancer (Ma et al., 2019; Zhu et al., 2019). The gene discussed is COL1A1; the disease is urinary bladder cancer.